Effects of Adding Hypertonic Saline Solutions and/or Etilefrine to Standard Diuretics Therapy in Hepatic Ascites
Status:
Completed
Trial end date:
2020-04-30
Target enrollment:
Participant gender:
Summary
This work aimed to evaluate and compare the impact of adding hypertonic saline solution (HSS)
infusion and/or etilefrine to oral diuretics therapy on clinical outcomes, renal and systemic
hemodynamics, metabolic and inflammatory pathways by estimating the changes in selected
biological markers in cirrhotic patients with ascites. Also, the trial aims to assess the
safety and tolerability of such treatment regimens.